Shareholders Equity (Tables)

12 Months Ended

Dec. 31, 2019

Shareholders' Equity

Schedule of purchases of equity Shares

The following table contains information about our repurchase of equity securities during the year ended December 31, 2019:

				Total number		Maximum number
				of shares		of shares that
				purchased as		may yet be
	Total number	Average price		part of publicly		purchased under
	of shares	paid per		announced plans		the plans or
	purchased	share		or programs		programs
Beginning balance at May 20, 2019					—		1,367,762
May 2019	16,148	$	4.17
June 2019	221,041	$	4.12
July 2019	55,112	$	3.90
August 2019	56,432	$	3.66
September 2019	14,797	$	3.79
October 2019	42,307	$	3.38
November 2019	290,259	$	3.41
Total for the year ended December 31, 2019	696,096	$	3.72		696,096		671,666

Summary of stock option activity

	Year ended			Year ended
	December 31, 2019			December 31, 2018
		Weighted				Weighted
	Number of	Average		Number of		Average
	Options	Exercise		Options		Exercise
Exercise price in US$	Outstanding	Price (1)		Outstanding		Price (1)
Balance at beginning of period	290,750	$	5.02		330,750	$	5.14
Exercised	(25,000)		2.17		—		—
Expired/Forfeited	(20,750)		5.37		(40,000)		6.00
Balance at period-end	245,000	$	5.27		290,750	$	5.02
Exercisable at period-end	206,670	$	5.32		210,249	$	5.02

Summary of stock options outstanding

					Weighted
			Option		Average
	Number of	Number of	Pricing		Remaining
	Options	Options	Model		Contractual Life
Exercise Price	Outstanding	Exercisable	Valuations		(in years)
As of December 31, 2019
$5.02	115,000	76,670	$	201,630	4.08
$5.50	130,000	130,000		276,299	2.43
Total	245,000	206,670	$	477,929	3.04

Schedule of restricted stock activity

	Year ended		Year ended
	December 31, 2019		December 31, 2018
		Weighted		Weighted
	Number of	Average	Number of	Average
	Shares	Remaining Life	Shares	Remaining Life
	Outstanding	(years)	Outstanding	(years)
Balance non-vested Restricted Stock at beginning of period	282,833	2.56	162,500	1.87
Granted	184,500	3.00	174,500	3.00
Vested	(106,834)	—	(54,167)	—
Forfeited	(14,000)	2.64	—	—
Balance non-vested Restricted Stock at end of period	346,499	1.67	282,833	2.56